During the past decade, Toranomon Hospital Kajigaya conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toranomon Hospital Kajigaya" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Toranomon Hospital Kajigaya" are "Nonalcoholic Steatohepatitis" (2 trials), "Anemia" (1 trials), "Cancer, Hepatocellular" (1 trials), "Polycystic Kidney Disease, Autosomal Dominant" (1 trials) and "Renal Insufficiency, Chronic" (1 trials). Many other conditions were trialed in "Toranomon Hospital Kajigaya" in a lesser frequency.

Most popular intervention types in "Toranomon Hospital Kajigaya" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials), "Molidustat (BAY85-3934)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toranomon Hospital Kajigaya" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Toranomon Hospital Kajigaya". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Toranomon Hospital Kajigaya, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Toranomon Hospital Kajigaya, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".